Sarcopenia clinical trials at University of California Health

3 in progress, 2 open to eligible people

Showing trials for

  • Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients

    open to eligible people ages 18 years and up

    This study examines the acceptability, feasibility, and safety in developing a prehabilitation program for head and neck cancer patients. The purpose of this research is to access the safety and acceptability of using a prehabilitation program before head and neck cancer surgery.

    at UC Davis

  • Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty

    open to eligible people ages 18 years and up

    Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree of muscle wasting, is closely correlated to frailty and patient outcomes. This is a prospective cohort study of critically ill patients to identify modifiable risk factors of sarcopenia, as potential targets to reduce frailty.

    at UCLA

  • Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis

    Sorry, not yet accepting patients

    Frailty and muscle health are important for patients with chronic liver disease. This study looks at the use of a digital prehabilitation app (HEAL-ME) plus creatine and whey protein combination supplementation on maintaining muscle health in patients with liver disease. The investigators anticipate that this combination of supplementation and nutrition/exercise prehabilitation app will maintain muscle health in patients with liver disease.

    at UCSF

Our lead scientists for Sarcopenia research studies include .

Last updated: